Healthcare -
Drug Manufacturers - General - NASDAQ - US
$ 140.55
-0.481 %
$ 20.5 B
Market Cap
12.72
P/E
BIIB - COST OF REVENUE
Cost of Revenue BIIB - Biogen Inc.
2.53 B
LAST VALUE
9.58%
2 YEAR CAGR
6.88%
5 YEAR CAGR
11.44%
10 YEAR CAGR